Valeant Withdraws Sweetened Bid for ISTA -
January 30, 2012
The Canadian pharmaceuticals firm also said it's seeking a $500 million term loan B to refinance debt and fund future possible acquisitions...
The full article is available to Leveraged subscribers only
Already a print subscriber? As a print subscriber, you are entitled to online access. Please click here to activate your account.

